Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.314
+0.017 (5.76%)
Nov 4, 2024, 3:59 PM EST - Market closed
Oragenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 0.01 | 0.04 | 0.13 | 0.09 | - | - | Upgrade
|
Revenue Growth (YoY) | -93.58% | -71.37% | 51.20% | - | - | - | Upgrade
|
Cost of Revenue | 13.38 | 15.49 | 10.07 | 10.59 | 22.11 | - | Upgrade
|
Gross Profit | -13.37 | -15.45 | -9.94 | -10.5 | -22.11 | - | Upgrade
|
Selling, General & Admin | 6.28 | 5.45 | 4.48 | 5.27 | 4.53 | 3.76 | Upgrade
|
Research & Development | - | - | - | - | - | 12.12 | Upgrade
|
Other Operating Expenses | - | - | - | 0 | 0 | 0 | Upgrade
|
Operating Expenses | 6.28 | 5.45 | 4.48 | 5.27 | 4.54 | 15.88 | Upgrade
|
Operating Income | -19.66 | -20.9 | -14.42 | -15.77 | -26.64 | -15.88 | Upgrade
|
Interest Expense | -0.04 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | Upgrade
|
Interest & Investment Income | 0.11 | 0.21 | 0.14 | 0.08 | 0.09 | 0.32 | Upgrade
|
Other Non Operating Income (Expenses) | 0.07 | 0.07 | 0.01 | 0 | 0 | 0 | Upgrade
|
EBT Excluding Unusual Items | -19.52 | -20.66 | -14.29 | -15.71 | -26.56 | -15.57 | Upgrade
|
Other Unusual Items | - | - | - | - | 0.13 | - | Upgrade
|
Pretax Income | -19.52 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
Earnings From Continuing Operations | -19.52 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
Net Income | -19.52 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
Net Income to Common | -19.52 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 1 | 1 | Upgrade
|
Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 1 | 1 | Upgrade
|
Shares Change (YoY) | 58.10% | 11.97% | 3.40% | 106.24% | 33.69% | 224.29% | Upgrade
|
EPS (Basic) | -6.02 | -9.18 | -7.11 | -8.09 | -28.05 | -22.09 | Upgrade
|
EPS (Diluted) | -6.02 | -9.18 | -7.11 | -8.09 | -28.05 | -22.09 | Upgrade
|
Free Cash Flow | -7.21 | -7.29 | -15.36 | -13.51 | -16.95 | -13.04 | Upgrade
|
Free Cash Flow Per Share | -2.22 | -3.24 | -7.64 | -6.95 | -17.99 | -18.50 | Upgrade
|
Operating Margin | -263285.20% | -55519.89% | -10964.61% | -18131.88% | - | - | Upgrade
|
Profit Margin | -261401.51% | -54858.14% | -10863.96% | -18062.03% | - | - | Upgrade
|
Free Cash Flow Margin | -96629.19% | -19363.34% | -11675.70% | -15535.76% | - | - | Upgrade
|
EBITDA | -19.64 | -20.88 | -14.38 | -15.73 | -26.59 | -15.82 | Upgrade
|
D&A For EBITDA | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | Upgrade
|
EBIT | -19.66 | -20.9 | -14.42 | -15.77 | -26.64 | -15.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.